Free tool
Diagnostics stocks
We cover 31 companies grouped under the Diagnostics theme. The median market value in the group is $413.78M. Across the group, the median move over the past trading day is +1.00%. 55% of the 31 with a 200-day average trade above it. Price change over the past year runs from −83.8% to +107.9% across the middle 80 percent of the group, with a median of −10.7%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
31 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| QGEN | Qiagen N.V. | $9.01B | Mid cap | −10.74% | Nov 4, 2026 |
| QIA.DE | Qiagen N.V. | $8.85B | Mid cap | −11.42% | Nov 4, 2026 |
| 6869.T | Sysmex Corporation | $7.42B | Mid cap | +5.65% | Nov 4, 2026 |
| CAI | Caris Life Sciences, Inc. | $7.38B | Mid cap | −27.21% | Nov 4, 2026 |
| BLLN | BillionToOne, Inc. | $4.72B | Mid cap | −8.14% | Nov 5, 2026 |
| WGS | GeneDx Holdings Corp. | $2.61B | Mid cap | −28.28% | Oct 27, 2026 |
| NEOG | Neogen Corporation | $2.54B | Mid cap | +107.86% | Oct 8, 2026 |
| NEO | NeoGenomics, Inc. | $2.19B | Mid cap | +160.31% | Oct 27, 2026 |
| ALIF-B.ST | AddLife AB (publ) | $2.09B | Mid cap | −7.56% | Oct 21, 2026 |
| PSNL | Personalis, Inc. | $1.84B | Small cap | +267.02% | Nov 3, 2026 |
| DIA.WA | Diagnostyka S.A. | $1.54B | Small cap | −17.53% | Sep 10, 2026 |
| 4544.T | H.U. Group Holdings, Inc. | $1.26B | Small cap | +11.45% | Nov 11, 2026 |
| OPK | OPKO Health, Inc. | $1.11B | Small cap | +7.19% | Oct 28, 2026 |
| QDEL | QuidelOrtho Corporation | $1.03B | Small cap | −45.57% | Nov 5, 2026 |
| 4694.T | BML, Inc. | $862.01M | Small cap | +7.64% | Nov 6, 2026 |
| CEVI.ST | CellaVision AB (publ) | $413.78M | Small cap | −3.32% | Oct 28, 2026 |
| NIOX.L | NIOX Group Plc | $382.51M | Small cap | −6.05% | Sep 29, 2026 |
| 0KCC.L | Insight Molecular Diagnostics Inc. | $339.65M | Small cap | +80.26% | Nov 9, 2026 |
| SBS.DE | Stratec SE | $324.34M | Small cap | −16.29% | Nov 12, 2026 |
| BDSX | Biodesix, Inc. | $296.22M | Small cap | +186.48% | Nov 3, 2026 |
| 0RAR.L | Stratec SE | $275.63M | Small cap | −13.37% | Nov 12, 2026 |
| OSUR | OraSure Technologies, Inc. | $260.70M | Small cap | +20.38% | Nov 4, 2026 |
| LUCD | Lucid Diagnostics Inc. | $190.95M | Small cap | −12.93% | Nov 11, 2026 |
| IMDX | Insight Molecular Diagnostics Inc. | $145.30M | Small cap | +78.31% | Nov 9, 2026 |
| SERA | Sera Prognostics, Inc. | $86.00M | Micro cap | −17.42% | Nov 16, 2026 |
| MDXH | MDxHealth SA | $70.73M | Micro cap | −83.84% | Nov 12, 2026 |
| PAVM | PAVmed Inc. | $40.78M | Micro cap | −64.04% | Nov 12, 2026 |
| CODX | Co-Diagnostics, Inc. | $7.63M | Micro cap | −87.07% | Nov 16, 2026 |
| CDIO | Cardio Diagnostics Holdings, Inc. | $5.65M | Micro cap | −45.58% | Nov 6, 2026 |
| VNRX | VolitionRx Limited | $5.25M | Micro cap | −97.21% | Nov 12, 2026 |
| REVB | Revelation Biosciences, Inc. | $3.98M | Micro cap | −91.21% | Nov 5, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.